Cargando…
Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
A strategy for preparing composite micelles (CM) containing both cisplatin(IV) [CisPt(IV)] prodrug and capecitabine using a co-assembly method is described in this study. The CM are capable of an effective release of the anticancer drug cisplatin(II) [CisPt(II)] and capecitabine via acid hydrolysis...
Autores principales: | Xiao, Xiao, Wang, Ting, Li, Leijiao, Zhu, Zhongli, Zhang, Weina, Cui, Guihua, Li, Wenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390499/ https://www.ncbi.nlm.nih.gov/pubmed/30837877 http://dx.doi.org/10.3389/fphar.2019.00110 |
Ejemplares similares
-
The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting
por: Sun, Meng, et al.
Publicado: (2021) -
Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
por: Sun, Chao-Yue, et al.
Publicado: (2018) -
Synthesis, Anti-Tumor Activity and Apoptosis-Inducing Effect of Novel Dimeric Keggin-Type Phosphotungstate
por: Xue, Yingxue, et al.
Publicado: (2021) -
Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice
por: Timmers, Lonneke, et al.
Publicado: (2016) -
Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study
por: Maeda, Osamu, et al.
Publicado: (2017)